BioNTech.de Funding: $595M Raised, Series B (2019)
BioNTech.de has raised $595M in total funding. Latest round: Series B. Backed by Fidelity Management & Research Company, Redmile Group, Invus.
BioNTech.de funding overview
BioNTech.de has raised $595M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in July 2019. The round record for BioNTech.de runs through 2019; nothing later has been disclosed. Investors on record include Fidelity Management & Research Company, Redmile Group, Invus, MiraeAsset Financial Group, Platinum Asset Management, Jebsen Capital and 6 others. 12 distinct backers are named across the disclosed rounds.
BioNTech.de has raised $595M in total disclosed funding across the rounds on record.
Who has invested in BioNTech.de?
Fidelity Management & Research Company, Redmile Group, Invus, MiraeAsset Financial Group, Platinum Asset Management, Jebsen Capital are named among the investors backing BioNTech.de.
What was the latest BioNTech.de funding round?
The most recent disclosed round is a Series B, announced in July 2019.
Where is BioNTech.de based?
No headquarters location is disclosed for BioNTech.de.
When did BioNTech.de last raise?
The last disclosed BioNTech.de round closed in July 2019 at Series B.
Every BioNTech.de figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies at a similar stage.
